Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Jan 11;22(1):128-138.
doi: 10.1093/neuonc/noz154.

Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas

Aurore Surun  1   2 , Pascale Varlet  2   3 , Laurence Brugières  4 , Brigitte Lacour  5 , Cécile Faure-Conter  6 , Pierre Leblond  7 , Anne-Isabelle Bertozzi-Salomon  8 , Claire Berger  9 , Nicolas André  10 , Eric Sariban  11 , Sandra Raimbault  4 , Fabienne Prieur  12 , Françoise Desseigne  13 , Hélène Zattara  14 , Rosine Guimbaud  15 , Marc Polivka  16 , Marie-Bernadette Delisle  17 , Alexandre Vasiljevic  18 , Claude-Alain Maurage  19 , Dominique Figarella-Branger  20 , Florence Coulet  21 , Léa Guerrini-Rousseau  4 , Claire Alapetite  22 , Christelle Dufour  4 , Chrystelle Colas  23 , François Doz  1   2 , Franck Bourdeaut  1
Affiliations
Observational Study

Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomas

Aurore Surun et al. Neuro Oncol. .

Abstract

Background: Medulloblastomas may occur in a predisposition context, including familial adenomatosis polyposis. Medulloblastomas related to a germline pathogenic variant of adenomatous polyposis coli (APC) remain rare and poorly described. Their similarities with sporadic WNT medulloblastomas still require description.

Methods: We performed a multicentric retrospective review of 12 patients treated between 1988 and 2018 for medulloblastoma with an identified or highly suspected (personal or familial history) APC germline pathogenic variant. We report personal and familial history APC gene pathogenic variants whenever available: clinical and histologic characteristics of the medulloblastoma, treatments, and long-term outcome, including second tumor and late sequelae.

Results: Medulloblastomas associated with APC pathogenic variants are mainly classic (11/11 patients, 1 not available), nonmetastatic (10/12 patients) medulloblastomas, with nuclear immunoreactivity for ß-catenin (9/9 tested cases). Ten of 11 assessable patients are disease free with a median follow-up of 10.7 years (range, 1-28 y). Secondary tumors included desmoid tumors in 7 patients (9 tumors), 1 thyroid carcinoma, 2 pilomatricomas, 1 osteoma, 1 vertebral hemangioma, and 1 malignant triton in the radiation field, which caused the only cancer-related death in our series.

Conclusions: Medulloblastomas associated with an APC pathogenic variant have an overall favorable outcome, even for metastatic tumors. Yet, long-term survival is clouded by second tumor occurrence; treatment may play some role in some of these second malignancies. Our findings raise the question of applying a de-escalation therapeutic protocol to treat patients with APC germline pathogenic variants given the excellent outcome, and reduced intensity of craniospinal irradiation may be further evaluated.

Keywords: APC; Gardner syndrome; WNT; familial adenomatosis polyposis; medulloblastoma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Characteristics of patients and tumors. (A) Box-plot showing the age distribution at diagnosis, in years; line at median with interquartile range. (B) Distribution of presence (green) or absence (red) of personal (left) or familial (right) history of tumor at time of medulloblastoma diagnosis. (C) Absolute number of metastatic status (upper bar), classic histology (middle bar), and molecular subgroup (lower bar) of cases. NA = not available. (D) Axial (left panels) and coronal (right panel) MRI sections of 2 medulloblastomas from the cerebellopontine angle and the cerebellar peduncle.
Fig. 2
Fig. 2
Outcome: survival and second tumors. (A) Relative distribution of second tumors according to histologic subtype (number of patients). (B) Overall survival (OS) and (C) secondary tumor-free survival (STFS) (including desmoid tumor, malignant triton tumor, and thyroid carcinoma) according to the Kaplan–Meier method; time in years.
See this image and copyright information in PMC

Comment in

References

    1. Peris-Bonet R, Martínez-García C, Lacour B, et al. . Childhood central nervous system tumours–incidence and survival in Europe (1978-1997): report from Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2064–2080. - PubMed
    1. DeWitt JC, Mock A, Louis DN. The 2016 WHO classification of central nervous system tumors: what neurologists need to know. Curr Opin Neurol. 2017;30(6):643–649. - PubMed
    1. Gilbertson RJ, Ellison DW. The origins of medulloblastoma subtypes. Annu Rev Pathol. 2008;3:341–365. - PubMed
    1. Louis DN, Perry A, Reifenberger G, et al. . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803–820. - PubMed
    1. Ellison DW, Onilude OE, Lindsey JC, et al. ; United Kingdom Children’s Cancer Study Group Brain Tumour Committee beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children’s Cancer Study Group Brain Tumour Committee. J Clin Oncol. 2005;23(31):7951–7957. - PubMed

Publication types

LinkOut - more resources